Correlation Between Reviva Pharmaceuticals and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Reviva Pharmaceuticals and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Reviva Pharmaceuticals and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Reviva Pharmaceuticals Holdings and Blueprint Medicines Corp, you can compare the effects of market volatilities on Reviva Pharmaceuticals and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Reviva Pharmaceuticals with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Reviva Pharmaceuticals and Blueprint Medicines.
Diversification Opportunities for Reviva Pharmaceuticals and Blueprint Medicines
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Reviva and Blueprint is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Reviva Pharmaceuticals Holding and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Reviva Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Reviva Pharmaceuticals Holdings are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Reviva Pharmaceuticals i.e., Reviva Pharmaceuticals and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Reviva Pharmaceuticals and Blueprint Medicines
Given the investment horizon of 90 days Reviva Pharmaceuticals Holdings is expected to generate 3.26 times more return on investment than Blueprint Medicines. However, Reviva Pharmaceuticals is 3.26 times more volatile than Blueprint Medicines Corp. It trades about 0.09 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.18 per unit of risk. If you would invest 112.00 in Reviva Pharmaceuticals Holdings on September 1, 2024 and sell it today you would earn a total of 12.00 from holding Reviva Pharmaceuticals Holdings or generate 10.71% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Reviva Pharmaceuticals Holding vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Reviva Pharmaceuticals |
| Blueprint Medicines Corp |
Reviva Pharmaceuticals and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Reviva Pharmaceuticals and Blueprint Medicines
The main advantage of trading using opposite Reviva Pharmaceuticals and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Reviva Pharmaceuticals position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Reviva Pharmaceuticals vs. Tff Pharmaceuticals | Reviva Pharmaceuticals vs. Eliem Therapeutics | Reviva Pharmaceuticals vs. Inhibrx | Reviva Pharmaceuticals vs. Enliven Therapeutics |
| Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |